Study on Lipid Profile Changes in Plasma and Intestinal Mucosa of Patients With Inflammatory Bowel Disease

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorFirst Affiliated Hospital of Harbin Medical University

About this trial

This study aimed to demonstrate the characteristic lipid profile changes in patients with inflammatory bowel disease.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients with inflammatory bowel disease; aged 18-80 years; all cases agreed to participate in the study.

Healthy volunteers who agreed to participate in the study.

Disqualifiers

Patients with severe heart disease; patients with severe kidney disease; patients with low blood pressure; patients with severe infections such as sepsis or pneumonia; patients who have used immunosuppressants such as 6-mercaptopurine, imidazole thiopurine, and cyclosporine within a short period, and women during pregnancy; patients who are post-colon resected; patients who disagreed to participate in the study.

Trial population

Healthy volunteers and patients who have inflammation bowel disease.

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

90 Participants
are grouped into 2 trial groups
Group A: Disease group
Group B: Health group

Trial outcomes

Primary outcomes

1

Differential lipid composition between disease and healthy groups

Differences in lipid composition between disease and healthy groups.

Time frame
14 weeks
2

Differences in lipid composition between active and remission disease

Differences in lipid composition between active and remission disease

Time frame
14 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: